Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme

Nucleic Acids Research

Volumn 43, Issue 19, 2015, Pages 9340-9349

  Caval, Vincent ^a   Bouzidi, Mohamed S ^a   Suspène, Rodolphe ^a   Laude, Hélène ^a   Dumargne, Marie Charlotte ^a   Bashamboo, Anu ^a   Krey, Thomas ^a   Vartanian, Jean Pierre ^a   Wain Hobson, Simon ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE LIKE 3B; CYTIDINE DEAMINASE; EXTRACHROMOSOMAL DNA; SINGLE STRANDED DNA; UNCLASSIFIED DRUG; APOBEC3A PROTEIN, HUMAN; APOBEC3B PROTEIN, HUMAN; MINOR HISTOCOMPATIBILITY ANTIGEN; PROTEIN;

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA BINDING; DOUBLE STRANDED DNA BREAK; ENZYME ACTIVITY; IN VITRO STUDY; NEOPLASM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SOMATIC MUTATION; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; HELA CELL LINE; HUMAN; METABOLISM; MUTATION; PROTEIN TERTIARY STRUCTURE; QUAIL; RHESUS MONKEY; RNA EDITING;

ANIMALS; CELL LINE; CYTIDINE DEAMINASE; DNA BREAKS, DOUBLE-STRANDED; HELA CELLS; HUMANS; MACACA MULATTA; MINOR HISTOCOMPATIBILITY ANTIGENS; MUTATION; PHENOTYPE; PROTEIN STRUCTURE, TERTIARY; PROTEINS; QUAIL; RNA EDITING;

EID: 84959423364     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv935     Document Type: Article

References (38)

1. Bignell,G.R., Greenman,C.D., Davies,H., Butler,A.P., Edkins,S., Andrews,J.M., Buck,G., Chen,L., Beare,D., Latimer,C. et al. (2010) Signatures of mutation and selection in the cancer genome. Nature, 463, 893-898.
2. Greenman,C., Stephens,P., Smith,R., Dalgliesh,G.L., Hunter,C., Bignell,G., Davies,H., Teague,J., Butler,A., Stevens,C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature, 446, 153-158.
3. Lengauer,C., Kinzler,K.W. and Vogelstein,B. (1998) Genetic instabilities in human cancers. Nature, 396, 643-649.
4. Alexandrov,L.B., Nik-Zainal,S., Wedge,D.C., Aparicio,S.A, Behjati,S., Biankin,A.V., Bignell,G.R., Bolli,N., Borg,A., Borresen-Dale,A.-L. et al. (2013) Signatures of mutational processes in human cancer. Nature, 500, 415-421.
5. Burns,M.B., Lackey,L., Carpenter,M.A., Rathore,A., Land,A.M., Leonard,B., Refsland,E.W., Kotandeniya,D., Tretyakova,N., Nikas,J.B. et al. (2013) APOBEC3B is an enzymatic source of mutation in breast cancer. Nature, 494, 366-370.
6. Caval,V., Suspène,R., Shapira,M., Vartanian,J.-P. and Wain-Hobson,S. (2014) A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3′UTR enhances chromosomal DNA damage. Nat. Commun., 5, 5129.
7. Komatsu,A., Nagasaki,K., Fujimori,M., Amano,J. and Miki,Y. (2008) Identification of novel deletion polymorphisms in breast cancer. Int. J. Oncol., 33, 261-270.
8. Nik-Zainal,S., Alexandrov,L.B., Wedge,D.C., Loo,P., Greenman,C.D., Raine,K., Jones,D., Hinton,J., Marshall,J., Stebbings,L.A. et al. (2012) Mutational processes molding the genomes of 21 breast cancers. Cell, 149, 979-993.
9. Suspène,R., Aynaud,M.M., Guétard,D., Henry,M., Eckhoff,G., Marchio,A., Pineau,P., Dejean,A., Vartanian,J.P. and Wain-Hobson,S. (2011) Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism. Proc. Natl. Acad. Sci. U.S.A., 108, 4858-4863.
10. Kostrzak,A., Henry,M., Demoyen,P.L., Wain-Hobson,S. and Vartanian,J.P. (2015) APOBEC3A catabolism of electroporated plasmid DNA in mouse muscle. Gene Therapy, 22, 96-103.
11. Stenglein,M.D., Burns,M.B., Li,M., Lengyel,J. and Harris,R.S. (2010) APOBEC3 proteins mediate the clearance of foreign DNA from human cells. Nat. Struct. Mol. Biol., 17, 222-229.
12. Roberts,S.A., Lawrence,M.S., Klimczak,L.J., Grimm,S.A., Fargo,D., Stojanov,P., Kiezun,A., Kryukov,G.V., Carter,S.L., Saksena,G. et al. (2013) An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet., 45, 970-976.
13. Stephens,P.J., McBride,D.J., Lin,M.-L., Varela,I., Pleasance,E.D., Simpson,J.T., Stebbings,L.A., Leroy,C., Edkins,S., Mudie,L.J. et al. (2009) Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature, 462, 1005-1010.
14. Long,J., Delahanty,R.J., Li,G., Gao,Y.T., Lu,W., Cai,Q., Xiang,Y.B., Li,C., Ji,B.T., Zheng,Y. et al. (2013) A common deletion in the APOBEC3 genes and breast cancer risk. J. Natl. Cancer Inst., 105, 573-579.
15. Xuan,D., Li,G., Cai,Q., Deming-Halverson,S., Shrubsole,M.J., Shu,X.-O., Kelley,M.C., Zheng,W. and Long,J. (2013) APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry. Carcinogenesis, 34, 2240-2243.
16. Zhang,T., Cai,J., Chang,J., Yu,D., Wu,C., Yan,T., Zhai,K., Bi,X., Zhao,H., Xu,J. et al. (2013) Evidence of associations of APOBEC3B gene deletion with susceptibility to persistent HBV infection and hepatocellular carcinoma. Hum. Mol. Genet., 22, 1262-1269.
17. Suspène,R., Aynaud,M.M., Vartanian,J.P. and Wain-Hobson,S. (2013) Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase. PLoS ONE, 8, e63461.
18. Jarmuz,A., Chester,A., Bayliss,J., Gisbourne,J., Dunham,I., Scott,J. and Navaratnam,N. (2002) An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics, 79, 285-296.
19. Hakata,Y. and Landau,N.R. (2006) Reversed functional organization of mouse and human APOBEC3 cytidine deaminase domains. J. Biol. Chem.281, 36624-36631.
20. Bonvin,M. and Greeve,J. (2007) Effects of point mutations in the cytidine deaminase domains of APOBEC3B on replication and hypermutation of hepatitis B virus in vitro. J. Gen. Virol., 88, 3270-3274.
21. Fu,Y., Ito,F., Zhang,G., Fernandez,B., Yang,H. and Chen,X.S. (2015) DNA Cytosine and Methylcytosine Deamination by APOBEC3B: Enhancing Methylcytosine Deamination by Engineering APOBEC3B. Biochem. J., doi:10.1042/BJ20150382.
22. Henry,M., Guétard,D., Suspène,R., Rusniok,C., Wain-Hobson,S. and Vartanian,J.P. (2009) Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. PLoS ONE, 4, e4277.
23. LaRue,R.S., Jónsson,S.R., Silverstein,K.A., Lajoie,M., Bertrand,D., El-Mabrouk,N., Hötzel,I., Andresdóttir,V., Smith,T.P. and Harris,R.S. (2008) The artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals. BMC Mol. Biol., 9, 104.
24. Munk,C., Willemsen,A. and Bravo,I.G. (2012) An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals. BMC Evol. Biol., 12, 71.
25. Mussil,B., Suspène,R., Aynaud,M.M., Gauvrit,A., Vartanian,J.P. and Wain-Hobson,S. (2013) Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death. PLoS ONE, 8, e73641.
26. Vartanian,J.P., Henry,M., Marchio,A., Suspène,R., Aynaud,M.M., Guétard,D., Cervantes-Gonzalez,M., Battiston,C., Mazzaferro,V., Pineau,P. et al. (2010) Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog., 6, e1000928.
27. Lalancette,C., Platts,A.E., Johnson,G.D., Emery,B.R., Carrell,D.T. and Krawetz,S.A. (2009) Identification of human sperm transcripts as candidate markers of male fertility. J. Mol. Med., 87, 735-748.
28. Rostkowski,M., Olsson,M.H., Sondergaard,C.R. and Jensen,J.H. (2011) Graphical analysis of pH-dependent properties of proteins predicted using PROPKA. BMC Struct. Biol., 11,6.
29. Baker,N.A., Sept,D., Joseph,S., Holst,M.J. and McCammon,J.A. (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U.S.A., 98, 10037-10041.
30. Thielen,B.K., McNevin,J.P., McElrath,M.J., Hunt,B.V., Klein,K.C. and Lingappa,J.R. (2010) Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms. J. Biol. Chem., 285, 27753-27766.
31. Suspène,R., Henry,M., Guillot,S., Wain-Hobson,S. and Vartanian,J.P. (2005) Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. J. Gen. Virol., 86, 125-129.
32. Mitra,M., Hercik,K., Byeon,I.J., Ahn,J., Hill,S., Hinchee-Rodriguez,K., Singer,D., Byeon,C.-H., Charlton,L.M., Nam,G. et al. (2014) Structural determinants of human APOBEC3A enzymatic and nucleic acid binding properties. Nucleic Acids Res., 42, 1095-1110.
33. Caval,V., Suspène,R., Vartanian,J.P. and Wain-Hobson,S. (2014) Orthologous mammalian APOBEC3A cytidine deaminases hypermutate nuclear DNA. Mol. Biol. Evol., 31, 330-340.
34. Rogozin,I.B., Basu,M.K., Jordan,I.K., Pavlov,Y.I. and Koonin,E.V. (2005) APOBEC4, a new member of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases predicted by computational analysis. Cell Cycle, 4, 1281-1285.
35. Aynaud,M.M., Suspène,R., Vidalain,P.O., Mussil,B., Guétard,D., Tangy,F., Wain-Hobson,S. and Vartanian,J.-P. (2012) Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A. J. Biol. Chem. 287, 39182-39192.
36. Koning,F.A., Newman,E.N., Kim,E.-Y., Kunstman,K.J., Wolinsky,S.M. and Malim,M.H. (2009) Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virol, 83, 9474-9485.
37. Kidd,J.M., Newman,T.L., Tuzun,E., Kaul,R. and Eichler,E.E. (2007) Population stratification of a common APOBEC gene deletion polymorphism. PLoS Genet., 3, e63.
38. Harris,K. (2015) Evidence for recent, population-specific evolution of the human mutation rate. Proc. Natl. Acad. Sci. U.S.A., 112, 3439-3444.